International journal of nanomedicine · 2025
Layer-by-Layer Engineering of Black Seed Oil Based SNEDDSs (BSO-SNEDDSs): Optimizing Chemical Stability and Bioavailability in Ramipril Formulations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shahba Ahmad Abdul-Wahhab, Sherif Abdelrahman Y, Elzayat Ehab M, Ali Shaukat, Kazi Mohsin
Аннотация
PURPOSE: The inherent chemical instability of ramipril (RMP) can lead to reduced therapeutic efficacy and safety, emphasizing the need for innovative formulation strategies for increased stability and bioavailability. This study aims to develop RMP-loaded liquid and solid self-nanoemulsifying formulations (SNEDDSs) that incorporate cardioprotective black seed oil (BSO) as a natural source of bioactive thymoquinone (THQ) for comprehensive chemical stability and pharmacokinetic evaluation.
METHODS: A systematic approach was employed to transform liquid SNEDDSs into both single-layer (Single-SNEPs) and multilayer (Multi-SNEPs) self-nanoemulsifying pellets through fluid bed coating technology. Extensive characterization encompassing morphological analysis, dissolution studies, chemical stability assessments, and pharmacokinetic profiling, was conducted.
RESULTS: In vitro dissolution studies demonstrated that the multilayered 5L-SNEPs formulation exhibited the highest dissolution efficiency compared with that of pure RMP (p > 0.05) and pure THQ (P < 0.05). Notably, the 5-layer pellets (5L-SNEPs) exhibited superior chemical stability of RMP (p < 0.05) compared with the liquid SNEDDS and other pellet variants. In-vivo pharmacokinetic analysis in rats revealed that liquid SNEDDS showed a numerically greater maximum plasma concentration (Cmax = 106 ± 34 ng/mL) and area under the curve (AUC = 454 ± 265 ng·h/mL) compared to pure RMP (Cmax = 90 ± 17 ng/mL; AUC = 308 ± 213 ng·h/mL), indicating a 1.5-fold higher AUC from the liquid SNEDDS. However, the difference was not statistically significant. Interestingly, 5L-SNEPs resulted in the lowest RMP exposure among the tested formulations, with a Cmax of 60 ± 18 ng/mL and an AUC of 155 ± 59 ng·h/mL, although the differences were not statistically significant compared to the other groups. The time to maximum concentration (Tmax) was 0.8 hours for liquid SNEDDS, 0.6 hours for the 5L-SNEPs, and 0.5 hours for pure RMP.
CONCLUSION: While liquid SNEDDSs exhibit promisingly greater oral bioavailability than crystalline drugs do, the performance of multilayer solid SNEDDSs necessitates further refinement. Nonetheless, this comprehensive investigation establishes a robust foundation for continued research on multifunctional bioactive oil-based SNEDDSs to enhance the bioavailability of drugs with limited water solubility.
METHODS: A systematic approach was employed to transform liquid SNEDDSs into both single-layer (Single-SNEPs) and multilayer (Multi-SNEPs) self-nanoemulsifying pellets through fluid bed coating technology. Extensive characterization encompassing morphological analysis, dissolution studies, chemical stability assessments, and pharmacokinetic profiling, was conducted.
RESULTS: In vitro dissolution studies demonstrated that the multilayered 5L-SNEPs formulation exhibited the highest dissolution efficiency compared with that of pure RMP (p > 0.05) and pure THQ (P < 0.05). Notably, the 5-layer pellets (5L-SNEPs) exhibited superior chemical stability of RMP (p < 0.05) compared with the liquid SNEDDS and other pellet variants. In-vivo pharmacokinetic analysis in rats revealed that liquid SNEDDS showed a numerically greater maximum plasma concentration (Cmax = 106 ± 34 ng/mL) and area under the curve (AUC = 454 ± 265 ng·h/mL) compared to pure RMP (Cmax = 90 ± 17 ng/mL; AUC = 308 ± 213 ng·h/mL), indicating a 1.5-fold higher AUC from the liquid SNEDDS. However, the difference was not statistically significant. Interestingly, 5L-SNEPs resulted in the lowest RMP exposure among the tested formulations, with a Cmax of 60 ± 18 ng/mL and an AUC of 155 ± 59 ng·h/mL, although the differences were not statistically significant compared to the other groups. The time to maximum concentration (Tmax) was 0.8 hours for liquid SNEDDS, 0.6 hours for the 5L-SNEPs, and 0.5 hours for pure RMP.
CONCLUSION: While liquid SNEDDSs exhibit promisingly greater oral bioavailability than crystalline drugs do, the performance of multilayer solid SNEDDSs necessitates further refinement. Nonetheless, this comprehensive investigation establishes a robust foundation for continued research on multifunctional bioactive oil-based SNEDDSs to enhance the bioavailability of drugs with limited water solubility.